Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 2005

View Archived Issues

HCV-ABXTL-68 shows antiviral activity in liver transplant recipients

Promising results reported from a phase Ib trial on VX-950 in hepatitis C

Escitalopram reported effective in patients with obsessive-compulsive disorder

A new trial announced on Vytorin in patients with acute coronary syndromes

FG-4592: A selective and potent oral erythropoietic agent from FibroGen

Preclinical data on GSK's new TRPV1 antagonist

BNP-054: oral treatment for hypertension

New data on Novartis' competitive NMDA 1A/2A receptor antagonist

Adherex outlines development plans for chemoenhancer eniluracil

SIGA Technologies presents smallpox drug SIGA-246 to WHO

Hexal launches Labopharm's once-daily tramadol product in Germany

ID Biomedical securityholders vote to approve acquisition by GSK

FDA meets to consider pneumococcal conjugate vaccine approvals

Pancrastatin derivative exhibits potent antitumor activity in vivo but not in vitro

Actelion and UCB replace license agreement for Zavesca

SMP-534 effective in treating diabetic nephropathy in db/db mice

Gene therapy as an adjunct to standard MI treatment

Pharmion withdraws Vidaza MAA

SGN-33 begins phase I study for AML and MDS patients

TMC-125 begins phase III program

ZC-423: A novel PDB dimer with remarkable antitumor efficacy

Corgentech and AlgoRx mail definitive proxy for proposed merger

Tysabri sBLA for MS granted priority review

Eisai resubmits rufinamide NDA

Cubicin recommended for approval in Europe

SERMs described in Council of Scientific and Industrial Research patent

Recent patents disclose new analgesic agents

Recent patents report novel treatment options for respiratory disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...